These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32611516)

  • 21. Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.
    Sampedro-Núñez M; Luque RM; Ramos-Levi AM; Gahete MD; Serrano-Somavilla A; Villa-Osaba A; Adrados M; Ibáñez-Costa A; Martín-Pérez E; Culler MD; Marazuela M; Castaño JP
    Oncotarget; 2016 Feb; 7(6):6593-608. PubMed ID: 26673010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases.
    Dogeas E; Karagkounis G; Heaphy CM; Hirose K; Pawlik TM; Wolfgang CL; Meeker A; Hruban RH; Cameron JL; Choti MA
    J Am Coll Surg; 2014 Apr; 218(4):628-35. PubMed ID: 24655849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative single-cell RNA sequencing (scRNA-seq) reveals liver metastasis-specific targets in a patient with small intestinal neuroendocrine cancer.
    Rao M; Oh K; Moffitt R; Thompson P; Li J; Liu J; Sasson A; Georgakis G; Kim J; Choi M; Powers S
    Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32054662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STK33 Promotes the Growth and Progression of Human Pancreatic Neuroendocrine Tumour via Activation of the PI3K/AKT/mTOR Pathway.
    Zhou B; Xiang J; Zhan C; Liu J; Yan S
    Neuroendocrinology; 2020; 110(3-4):307-320. PubMed ID: 31261148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small Cystic Pancreatic Neuroendocrine Neoplasm with Huge Liver and Bone Metastases.
    Yasuda M; Takeda S; Lee M; Hoshi S; Hoshi T; Tanaka Y; Miyajima S; Takaya H; Kajimura K
    Intern Med; 2020; 59(23):3027-3032. PubMed ID: 33268697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulated Pancreatic Beta Cell Genes Indicate Poor Prognosis in Patients With Pancreatic Neuroendocrine Neoplasms.
    Kudo A; Akahoshi K; Ito S; Akashi T; Shimada S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Tateishi U; Tanaka S; Tanabe M
    Ann Surg; 2020 Apr; 271(4):732-739. PubMed ID: 29979246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine Tumors of the Pancreatobiliary and Gastrointestinal Tracts.
    Bonds M; Rocha FG
    Surg Clin North Am; 2020 Jun; 100(3):635-648. PubMed ID: 32402306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.
    Kajtazi Y; Kaemmerer D; Sänger J; Schulz S; Lupp A
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2481-2493. PubMed ID: 31451931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
    Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
    Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
    Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
    Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors.
    Batukbhai BDO; De Jesus-Acosta A
    Pancreas; 2019 Jan; 48(1):9-21. PubMed ID: 30531241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors.
    Gloesenkamp CR; Nitzsche B; Ocker M; Di Fazio P; Quint K; Hoffmann B; Scherübl H; Höpfner M
    Int J Oncol; 2012 Mar; 40(3):876-88. PubMed ID: 22075556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCF-3-mediated transcription of lncRNA HNF1A-AS1 targeting oncostatin M expression inhibits epithelial-mesenchymal transition via TGFβ signaling in gastroenteropancreatic neuroendocrine neoplasms.
    Xue J; Bai J; Long Q; Wei Y; Pan J; Li X; Tang Q
    Aging (Albany NY); 2021 May; 13(10):14065-14077. PubMed ID: 34037532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients.
    Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R
    Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs).
    Zanini S; Renzi S; Giovinazzo F; Bermano G
    Front Endocrinol (Lausanne); 2020; 11():562505. PubMed ID: 33304317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The First Case Report of Robotic Multivisceral Resection for Synchronous Liver Metastasis from Pancreatic Neuroendocrine Tumor: A Case Report and Literature Review.
    Calin ML; Sadiq A; Arevalo G; Fuentes R; Flanders VL; Gupta N; Nasri B; Singh K
    J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):816-824. PubMed ID: 27454160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
    Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
    PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.